Tag: maintains

Mizuho maintains Outperform ranking on RPM Worldwide inventory, highlighting NovQ upside By Investing.com

On Thursday, Mizuho Securities maintained its optimistic stance on RPM Worldwide Inc.…

By Tycoon Herald 6 Min Read

JPMorgan raises Civitas Assets shares value goal, maintains Chubby ranking By Investing.com

JPMorgan has adjusted its outlook on Civitas Assets (NYSE: CIVI), elevating the…

By Tycoon Herald 6 Min Read

TD Cowen maintains Purchase ranking on Humacyte with $10 goal By Investing.com

On Monday, TD Cowen reaffirmed its Purchase ranking on shares of Humacyte…

By Tycoon Herald 5 Min Read

IperionX experiences annual outcomes, maintains stability in metals sector By Investing.com

CHARLOTTE, NC - IperionX Restricted, an organization specializing in miscellaneous steel ores,…

By Tycoon Herald 5 Min Read

WillScot maintains Outperform ranking from Oppenheimer with no change in goal worth By Investing.com

Oppenheimer has maintained its optimistic stance on WillScot (NASDAQ:) Cellular Mini (NASDAQ:)…

By Tycoon Herald 6 Min Read

ADB maintains development forecast for Creating Asia, says extra stimulus anticipated in China By Reuters

MANILA (Reuters) - Creating Asia is on monitor to develop 5% this…

By Tycoon Herald 5 Min Read

Needham cuts Workday shares goal, maintains Purchase ranking By Investing.com

Needham has maintained its Purchase ranking on Workday (NASDAQ: NASDAQ:) however decreased…

By Tycoon Herald 4 Min Read

Truist cuts Edwards Lifesciences inventory goal, however maintains Maintain score By Investing.com

Truist Securities has revised its value goal for shares of Edwards Lifesciences…

By Tycoon Herald 4 Min Read

TD Cowen maintains Purchase on Seres, cites optimistic examine information By Investing.com

On Thursday, TD Cowen expressed continued confidence in Seres Therapeutics (NASDAQ:), sustaining…

By Tycoon Herald 4 Min Read

Mizuho maintains Impartial ranking on BioXcel shares By Investing.com

Mizuho Securities has reiterated a Impartial ranking on BioXcel Therapeutics (NASDAQ: BTAI),…

By Tycoon Herald 5 Min Read